Cellebrite DI .(US:CLBT)2024-02-15 14:27Financial Highlights - Total Revenue for Q4 2023 reached $93 million, a 26% increase compared to $74 million in Q4 2022[16, 43] - Subscription Revenue for Q4 2023 was $79 million, also a 26% increase from the previous year[18, 44] - Annual Recurring Revenue (ARR) as of December 2023 reached $316 million, a 27% increase compared to December 2022's $249 million[18] - Adjusted EBITDA for Q4 2023 was $23 million, representing 24% of revenue, compared to $16 million in Q4 2022[18] - Cash and cash equivalents, short-term and long-term marketable securities were $331.8 million as of December 31, 2023[59] Growth Drivers - Revenue growth is primarily driven by subscription services[42] - ARR growth is fueled by expansion within the existing customer base[52] Financial Forecast - The company anticipates ARR between $325 million and $335 million for Q1 2024 and between $380 million and $400 million for FY 2024[75] - Revenue is projected to be between $83 million and $88 million for Q1 2024 and between $370 million and $380 million for FY 2024[75] - Adjusted EBITDA is expected to be between $12 million and $15 million for Q1 2024 and between $70 million and $80 million for FY 2024[75]